IRIS PubliCatt

Danese, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.423
NA - Nord America 2.013
AS - Asia 508
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 2
Totale 5.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.001
IT - Italia 1.177
DE - Germania 1.117
SE - Svezia 381
CN - Cina 307
UA - Ucraina 289
IE - Irlanda 109
FR - Francia 102
GB - Regno Unito 87
SG - Singapore 72
FI - Finlandia 57
IN - India 46
RU - Federazione Russa 45
TR - Turchia 45
JP - Giappone 14
RO - Romania 13
IR - Iran 11
BE - Belgio 7
CA - Canada 7
ES - Italia 7
NL - Olanda 7
HK - Hong Kong 6
CH - Svizzera 5
EU - Europa 4
AU - Australia 3
BZ - Belize 3
ME - Montenegro 3
PT - Portogallo 3
BR - Brasile 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
LK - Sri Lanka 2
MX - Messico 2
PL - Polonia 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 5.958
Salva come PNG Salva come JPEG
Città #
Chandler 418
Jacksonville 162
Ashburn 139
San Mateo 132
Milan 117
Dublin 107
Rome 93
Nanjing 80
Nürnberg 78
Wilmington 71
Ann Arbor 63
Dearborn 57
Boston 51
Princeton 46
Izmir 43
New York 39
Singapore 38
Munich 36
Redwood City 31
Woodbridge 31
Moscow 30
Nanchang 30
Turin 28
Houston 25
Palermo 25
Cattolica 22
Detroit 22
Seattle 22
Bremen 21
Hebei 20
Marseille 20
Mountain View 20
Lawrence 17
Shenyang 17
Bari 15
Fairfield 15
Kunming 15
University Park 15
Boardman 14
Bologna 14
Changsha 13
Beijing 12
Los Angeles 12
Zhengzhou 12
Jiaxing 11
Naples 11
Norwalk 11
Pune 11
Tianjin 11
Florence 10
Hangzhou 10
Treviso 10
Udine 10
Andover 9
Hefei 8
Jinan 8
Leawood 8
Simi Valley 8
Augusta 7
Dallas 7
Genoa 7
Lancaster 7
Napoli 7
San Jose 7
Shanghai 7
Botosani 6
Brussels 6
Costa Mesa 6
Garda 6
Helsinki 6
Hong Kong 6
Kish 6
Padova 6
Pavia 6
Redmond 6
Reggio Calabria 6
Torino 6
Buffalo 5
Caserta 5
Catania 5
Catanzaro 5
Chicago 5
Ferrara 5
Frankfurt am Main 5
Fremont 5
Guangzhou 5
Lanzhou 5
Messina 5
Sant'Agata di Militello 5
Vicenza 5
Viterbo 5
Carate Brianza 4
Fermo 4
Garbagnate Milanese 4
Genova 4
Kalispell 4
Leggiuno 4
Mumbai 4
Pescara 4
Potenza 4
Totale 2.651
Salva come PNG Salva come JPEG
Nome #
Ruolo dei fattori psicologici nelle malattie infiammatorie croniche intestinali 1.340
A) Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. 315
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. 200
-High prevalence of celiac disease in patients with lactose intolerance 170
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 149
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 132
Early atherosclerosis in patients with inflammatory bowel disease. 130
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 130
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations. 127
-Increased carotid intima-media thickness in patients with inflammatory bowel disease 118
Pathophysiology, diagnosis and treatment of non-erosive reflux disease (NERD) 117
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 113
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 108
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 94
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication 93
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 91
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 89
-Extraintestinal manifestations in inflammatory Bowel disease. 84
A novel pathogenic role for microvasculature in inflammatory bowel disease. 84
Gender, chronic infection and myocardial infarction 83
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 82
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. 81
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 80
Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients 77
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer. 74
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events 73
Severe liver injury associated with zafirlukast 70
Biological therapies for inflammatory bowel disease: research drives clinics. 66
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment 66
PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system. 65
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 65
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. 60
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 60
Elevated homocysteine levels in patients with Raynaud's syndrome 59
Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience 59
Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases 58
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 56
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 54
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement 53
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 53
-Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation 52
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 52
ag) CD40 antisense based strategy for inflammatory bowel disease: shutting down multiple cellular communication systems. 50
Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease 50
Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate 49
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial 49
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. 44
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 44
A) CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation. 42
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery 42
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 41
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 41
Folate in gastrointestinal health and disease 40
Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease 40
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 38
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting 38
ag) Antibody to alpha4beta7 integrin for ulcerative colitis. 36
Thrombotic complications in inflammatory bowel disease: a multifactorial etiology 34
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease 33
-Antibody to alpha4beta7 integrin for ulcerative colitis 31
Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels 30
ag) Chemokines in inflammatory bowel disease. 26
High prevalence of Helicobacter priori type I virulent strains in patients with systemic sclerosis [6] (multiple letters) 25
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 24
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study 2
Totale 6.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020787 158 48 56 43 71 81 64 31 49 44 76 66
2020/2021761 28 72 29 93 108 35 85 23 105 37 118 28
2021/2022689 48 66 19 49 32 18 17 127 27 38 113 135
2022/20231.309 146 164 101 202 95 156 66 117 154 26 42 40
2023/2024771 41 190 48 46 62 78 50 32 22 47 69 86
2024/202530 30 0 0 0 0 0 0 0 0 0 0 0
Totale 6.031